Single-cell integrated transcriptomics reveals the role of keratinocytes in head and neck squamous cell carcinoma

  • 0Department of Otorhinolaryngology Head and Neck Surgery, Xuanwu Hospital Capital Medical University, Beijing, China.

|

|

Summary

This summary is machine-generated.

This study reveals keratinocytes as key in head and neck squamous cell carcinoma (HNSCC). A new prognostic model aids in predicting HNSCC progression and identifying potential therapeutic targets.

Area Of Science

  • Oncology
  • Genomics
  • Molecular Biology

Background

  • Head and neck squamous cell carcinoma (HNSCC) presents significant challenges in morbidity and mortality.
  • Improved understanding of HNSCC molecular mechanisms, prognostic markers, and therapeutic targets is critical for patient outcomes.

Purpose Of The Study

  • To comprehensively analyze HNSCC at the cellular level using single-cell and bulk RNA sequencing.
  • To identify key cell types, gene modules, and prognostic markers involved in HNSCC progression.
  • To develop a predictive model for HNSCC prognosis and explore potential therapeutic strategies.

Main Methods

  • Utilized single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq data for HNSCC analysis.
  • Employed hdWGCNA co-expression network analysis to identify gene modules.
  • Constructed and validated a prognostic model using gene expression data.
  • Performed immune cell infiltration and signaling pathway analysis.
  • Conducted drug sensitivity analysis.

Main Results

  • Identified keratinocytes as the predominant cell type in HNSCC tumors.
  • Discovered gene modules significantly associated with HNSCC progression.
  • Developed a robust prognostic model with strong predictive performance across datasets.
  • Demonstrated correlations between the prognostic model, immune infiltration, and tumor progression pathways.
  • Identified potential chemotherapeutic targets based on drug sensitivity analysis.

Conclusions

  • Keratinocytes play a potential role in HNSCC development.
  • The developed prognostic model offers valuable insights for predicting HNSCC prognosis.
  • Findings illuminate the molecular landscape and immune microenvironment of HNSCC.
  • Potential therapeutic targets and strategies for HNSCC treatment have been identified.
  • Further research is needed to validate and translate these findings into clinical practice for improved HNSCC patient outcomes.